Results 161 to 170 of about 39,378 (264)
Optimal Stenting Strategy During Chemotherapy: Impact of Time to First Reintervention on Survival in Malignant Hilar Biliary Obstruction
DEN Open, Volume 7, Issue 1, April 2027.ABSTRACT Objectives
Advances in chemotherapy have increased survival in biliary tract cancer patients, and reports of the effectiveness of neoadjuvant therapy are emerging. Accordingly, developing optimal drainage strategies under chemotherapy is important.Katsuhiko Sato, Minoru Shigekawa, Teppei Yoshioka, Kazuma Daiku, Syuhei Yamamoto, Yu Sato, Takahiro Kodama, Hayato Hikita, Tetsuo Takehara +8 morewiley +1 more sourceThe combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study. [PDF]
Nat CommunLee V, Sachidanand AS, Rodriguez C, Wang J, Onners B, Qi H, Parkinson R, McPhaul T, Durham J, Ding D, Hacker-Prietz A, Narang AK, Le DT, De Jesus A, Pishvaian M, Christenson E, Thompson ED, Anders RA, Osipov A, Weiss M, Burns W, Burkhart R, Lafaro K, He J, Wolfgang CL, Sugar E, Herman JM, Jaffee EM, Wang H, Laheru DA, Zheng L. +30 moreeuropepmc +1 more sourceDevelopment and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real‐World Data With Insights From Pancreatic and Stomach Cancer
International Journal of Cancer, Volume 159, Issue 3, Page 757-767, 1 August 2026.Accurate cancer staging is essential for cancer research and treatment evaluation. However, real‐world data often include incomplete or inconsistent UICC staging classifications. The presented Munich UICC Staging Tool (MUST) automates UICC stage derivation from TNM classifications and tumor characteristics, incorporating novel real‐world data rules to ...Brigitte Kühnel, Sophie Schneiderbauer, Sebastian Lange, Dirk Wilhelm, Helmut Friess, Marcus Feith, Ursula Ehmer, Florian Bassermann, Julian W. Holch, Stefan M. Munker, Jens Neumann, Jens Werner, Hubert J. Stein, Theres Fey, Ulrich Mansmann, Hana Algül, Karin Berger‐Thürmel, H. Carlo Maurer, Daniel Nasseh +18 morewiley +1 more sourceFeasibility Study of Combined Systemic Therapy and Carbon‐Ion Radiotherapy for Hepatocellular Carcinoma Patients
Cancer Medicine, Volume 15, Issue 7, July 2026.ABSTRACT Background
Recent advances in systemic therapy, including tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs), have improved outcomes for hepatocellular carcinoma (HCC) and enabled downstaging strategies that allow subsequent local treatments. Carbon‐ion radiotherapy (CIRT) can provide excellent tumor control with minimal Daijiro Kobayashi, Kei Shibuya, Yuhei Miyasaka, Kenichiro Araki, Yuichi Yamazaki, Ken Shirabe, Tatsuya Ohno +6 morewiley +1 more sourceConventionally Fractionated Radiotherapy (CFRT) Versus Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis of Comparative Studies. [PDF]
Cancers (Basel)Montesi G, Miszczyk M, Niespolo RM, Capezzali G, Cellini F, D'Abbiero N, Fiore M, Genovesi D, La Macchia M, Lupattelli M, Mantello G, Matrone F, Nicosia L, Simoni N, Franco P, De Felice F. +15 moreeuropepmc +1 more sourceTherapeutic Potential of Berberis vulgaris in Modulating Metabolic Syndrome Biomarkers: Mechanistic Insights and Functional Food Implications
Food Frontiers, Volume 7, Issue 4, July 2026.ABSTRACT
Barberry (Berberis vulgaris) has emerged as a promising functional food candidate for the management of metabolic syndrome due to its diverse bioactive constituents, particularly berberine. This review synthesizes current experimental and clinical evidence regarding its effects on glycemic control, lipid metabolism, blood pressure regulation ...Fakhar Shahid, Ifrah Jabeen, Muhammad Inam‐ur‐Raheem, Amin Mousavi Khaneghah, Muhammad Abid, Rana Muhammad Aadil +5 morewiley +1 more sourceRadiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial.
JAMA Netw OpenSeelen LWF, Brada LJH, Walma MS, Rombouts SJE, Braat MN, Bollen TL, Borel Rinkes IH, Bruijnen RCG, Busch OR, Cirkel GA, Daamen LA, Daams F, van Dam RM, van Delden OM, Derksen WJM, Festen S, Groothuis K, Hagendoorn J, de Hingh IHJT, D'Hondt M, Liem MSL, van Lienden KP, Los M, de Meijer VE, Mekenkamp LJM, Nijkamp MW, Nio CY, Pando E, Patijn GA, Polée MB, Te Riele WW, Roeyen G, Stommel MWJ, de Vos-Geelen J, de Vries JJ, Wessels FJ, Wilmink JW, van de Ven PM, Besselink MG, van Santvoort HC, Molenaar IQ, Dutch Pancreatic Cancer Group. +41 moreeuropepmc +1 more sourceSafety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer. [PDF]
World J Surg OncolShimomura O, Numajiri H, Hashimoto S, Miyazaki Y, Doi M, Nakahashi H, Takahashi K, Hiroshima Y, Hasegawa N, Endo M, Niisato Y, Hagiwara Y, Yamamoto Y, Yamada T, Sakamoto N, Matsubara D, Mathis BJ, Tsuchiya K, Sakurai H, Oda T. +19 moreeuropepmc +1 more source